Literature DB >> 11885680

1.5-D high intensity focused ultrasound array for non-invasive prostate cancer surgery.

L Curiel, F Chavrier, R Souchon, A Birer, J Y Chapelon.   

Abstract

The aim of this study is to demonstrate the feasibility of a new spherically curved 1.5-D phased array for the treatment of localized prostatic cancer. The device is designed to conform to the Ablatherm machine (EDAP-Technomed, France), a commercially available machine in which high intensity focused ultrasound (HIFU) treatment for prostate cancer is administered transrectally. It uses high intensity electronically focused ultrasound to steer a beam along two axes, allowing enough depth to be reached to treat large prostates and eliminating two degrees of mechanical movement. Through computer simulation, it was determined that a curved 1.5-D configuration offered the optimal design. Two configurations were then proposed, and their ability to steer a beam within a target volume centered on the geometric focus of the transducer was simulated. An eight-element prototype was constructed to test the piezo-composite material and its electro-acoustical efficiency. Then, an array was constructed, and a multi-channel amplifier and control system were added, to permit remote operation. Acoustical and electrical measurements were made to verify performance. Finally, the 1.5-D array was tested in vitro on samples of pig liver to confirm the ability to induce lesions.

Entities:  

Mesh:

Year:  2002        PMID: 11885680     DOI: 10.1109/58.985707

Source DB:  PubMed          Journal:  IEEE Trans Ultrason Ferroelectr Freq Control        ISSN: 0885-3010            Impact factor:   2.725


  14 in total

1.  Experimental evaluation of lesion prediction modelling in the presence of cavitation bubbles: intended for high-intensity focused ultrasound prostate treatment.

Authors:  L Curiel; F Chavrier; B Gignoux; S Pichardo; S Chesnais; J Y Chapelon
Journal:  Med Biol Eng Comput       Date:  2004-01       Impact factor: 2.602

2.  64-element intraluminal ultrasound cylindrical phased array for transesophageal thermal ablation under fast MR temperature mapping: an ex vivo study.

Authors:  D Melodelima; R Salomir; C Mougenot; C Moonen; D Cathignol
Journal:  Med Phys       Date:  2006-08       Impact factor: 4.071

3.  Imaging arrays with improved transmit power capability.

Authors:  Michael J Zipparo; Kristin F Bing; Kathryn R Nightingale
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2010-09       Impact factor: 2.725

4.  Optimization of ultrasound array designs for high intensity focused treatment of prostate cancer and benign prostatic hyperplasia.

Authors:  Khaldon Lweesy; Luay Fraiwan; Osama Al-Bataineh; Naser Hamdi; Hartmut Dickhaus
Journal:  Med Biol Eng Comput       Date:  2009-03-27       Impact factor: 2.602

Review 5.  Image-guided ultrasound phased arrays are a disruptive technology for non-invasive therapy.

Authors:  Kullervo Hynynen; Ryan M Jones
Journal:  Phys Med Biol       Date:  2016-08-05       Impact factor: 3.609

6.  Imaging with concave large-aperture therapeutic ultrasound arrays using conventional synthetic-aperture beamforming.

Authors:  Yayun Wan; Emad S Ebbini
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2008-08       Impact factor: 2.725

7.  [HIFU in urological oncology].

Authors:  S Thüroff; C Chaussy
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

8.  Adaptive transthoracic refocusing of dual-mode ultrasound arrays.

Authors:  John R Ballard; Andrew J Casper; Yayun Wan; Emad S Ebbini
Journal:  IEEE Trans Biomed Eng       Date:  2009-07-31       Impact factor: 4.538

9.  HIFU Drive System Miniaturization Using Harmonic Reduced Pulsewidth Modulation.

Authors:  Chris Adams; Thomas M Carpenter; David Cowell; Steven Freear; James R McLaughlan
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2018-10-29       Impact factor: 2.725

10.  Transoesophageal ultrasound applicator for sector-based thermal ablation: first in vivo experiments.

Authors:  David Melodelima; Cyril Lafon; Frederic Prat; Yves Theillère; Alexei Arefiev; Dominique Cathignol
Journal:  Ultrasound Med Biol       Date:  2003-02       Impact factor: 2.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.